|
This conference will discuss a wide range of issues in the biomarker field specific to inflammatory and immunological therapeutic areas. Topics such as novel approaches to biomarker discovery, enabling technologies, regulatory and reimbursement trends and the development of companion diagnostics will be discussed. Specific disease areas include cardiovascular disease, metabolic diseases, arthritis, autoimmune diseases, kidney / renal disease and inflammatory bowel disease. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.
|